Jeena Sikho Lifecare Ltd
Pharmaceuticals & Biotechnology | Small Cap
Jeena Sikho Lifecare Ltd shows a mixed financial performance. The company demonstrates strong profitability, driven by impressive gross profit and operating margins, return on capital employed, and return on equity. Its solvency position is also strong, indicating a low reliance on debt. However, liquidity is a concern, as the company struggles to maintain adequate levels of current assets to cover short-term liabilities. Efficiency ratios are also mixed, with some areas needing improvements. The company faced significant revenue decline recently, impacting overall growth. While interest coverage is adequate, dividend coverage is weak. The financial ratios reflect low earnings and book value per share, offset partly by significant capital expenditure. Overall, the company excels in profitability and solvency but needs to address its liquidity and growth challenges to ensure long-term financial stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio3.60
- Profitability Ratio9.60
- Efficiency Ratio5.67
- Coverage Ratio7.60
- Solvency Ratio8.00
- Liquidity Ratio3.50
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursBearish
- 4 HoursBearish
- 1 DayStrong Bearish
- 1 WeekBearish
- 1 MonthNeutral
Jeena Sikho Lifecare Ltd shows a mixed financial performance. The company demonstrates strong profitability, driven by impressive gross profit and operating margins, return on capital employed, and return on equity. Its solvency position is also strong, indicating a low reliance on debt. However, liquidity is a concern, as the company struggles to maintain adequate levels of current assets to cover short-term liabilities. Efficiency ratios are also mixed, with some areas needing improvements. The company faced significant revenue decline recently, impacting overall growth. While interest coverage is adequate, dividend coverage is weak. The financial ratios reflect low earnings and book value per share, offset partly by significant capital expenditure. Overall, the company excels in profitability and solvency but needs to address its liquidity and growth challenges to ensure long-term financial stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
31.18
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
31.22
P/B RATIO
14.82
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
8.49
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.00
EV/EBITDA RATIO
19.04
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹557.2 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Concall Report⬤7th Nov 25
Q2 FY26 Earnings Conference Call
BULLISH SENTIMENT
The company's growth ratios reflect decline in key areas. There is a strong growth in net income, which is a positive sign. The challenges in revenue, operating profit, EPS, and asset growth indicate potential difficulties in expanding its operations and market presence. A focus on sustainable growth strategies is essential for long-term success.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 39.46 | 70.79 | ||
| Operating Profit Growth Rate | 155.56 | 147.52 | ||
| Earnings Per Share (EPS) Growth | 121.14 | 177.6 | ||
| Asset Growth Rate | 143.55 | 60.86 | ||
| Net Income Growth Rate | 209.09 | 177.5 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios indicate low earnings and book value per share. However, the company has been making considerable capital expenditures, which is a good sign for the company's future. Improving earnings and enhancing shareholder value are essential for strengthening its financial position.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 2 | 4.86 | 6.4 | 17.76 |
| Cash Earnings Per Share (Cash EPS) | 2.8 | 5.29 | 8.72 | 21.6 |
| Book Value Per Share | 7.2 | 18 | 20.48 | 37.36 |
| Dividend Per Share (DPS) | 0 | 0.22 | 0 | 4.46 |
| Capital Expenditures (CapEx) | 18 | 29 | 39 | 33 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios indicate strong performance. The company has high gross and operating profit margins, as well as excellent returns on capital employed, equity, and assets. This suggests efficient operations and effective management of resources. Maintaining this high profitability is crucial for sustaining competitiveness and shareholder value.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Profit Margin | 10.2 | 20.98 | 23.88 | 37.58 |
| Return on Capital Employed (ROCE) | 43.24 | 52 | 34.8 | 64 |
| Return on Equity (ROE) | 30.56 | 26.98 | 31.25 | 47.54 |
| Return on Assets (ROA) | 29.03 | 30.46 | 33.65 | 51.78 |
| Operating Margin | 12.24 | 22.44 | 30.06 | 43.57 |
| Net Margin | 7.48 | 16.59 | 17.06 | 27.72 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company demonstrates mixed efficiency. It has a slower turnover of fixed assets and capital, but an efficient inventory and receivables management. This balance suggests that the company is effectively managing some aspects of its operations while needing to optimize others. Efficient operations are crucial for sustaining competitiveness.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 5.07 | 3.42 | 1.84 | 2.72 |
| Inventory Turnover Ratio | 21.83 | 32.4 | 29.75 | 31.25 |
| Receivables Turnover Ratio | 15.87 | 13.23 | 5.53 | 10.34 |
| Days Sales in Inventory Ratio | 16.72 | 11.27 | 12.27 | 11.68 |
| Receivable Days | 23 | 27.59 | 66 | 35.3 |
| Capital Turnover Ratio | 3.97 | 1.61 | 1.37 | 1.35 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company has a strong ability to cover its interest expenses, but its equity dividend coverage is relatively weak. This suggests that while the company can manage its debt obligations effectively, distributing dividends to shareholders may be a challenge. Balancing debt and dividend obligations is crucial for long-term financial health.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Interest Coverage Ratio | 16 | 45 | 10.82 | 23.85 |
| Equity Dividend Coverage Ratio | 12.5 | 4 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position reflects a very low debt burden, as indicated by the debt, debt-to-equity, and debt-to-asset ratios. The equity ratio is weak, which balances out the overall standing. This suggests that the company relies heavily on equity financing, which can be a strength in terms of financial stability. Prudent financial management of capital is essential for maintaining a healthy solvency position.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debt Ratio | 0.03 | 0.01 | 0.25 | 0.21 |
| Debt to Equity Ratio | 0.03 | 0.01 | 0.33 | 0.27 |
| Equity Ratio | 0.97 | 0.99 | 0.75 | 0.79 |
| Debt To Asset Ratio | 0.02 | 0.01 | 0.21 | 0.19 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position shows some challenges. While the current, quick, and cash ratios suggest potential difficulties in meeting short-term obligations, the operating cash flow ratio indicates the company's ability to generate cash from its operations. Factors like the healthcare industry's cash flow cycles may affect these ratios, it's important for the company to manage its current assets and liabilities effectively to ensure financial stability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Current Ratio | 1.12 | 3.58 | 1.94 | 3.36 |
| Quick Ratio | 0.88 | 3.42 | 1.78 | 3.11 |
| Cash Ratio | 0.12 | 1.33 | 0.3 | 1.36 |
| Operating Cash Flow Ratio | 0.64 | 0.62 | 1.09 | 3.17 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Granules India Ltd | 7.73 | 32.77 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 2 | FDC Ltd | 7.64 | 22.52 | Neutral | 346.00 | 17.56 | 281.00 |
| 3 | Supriya Lifescience Ltd | 7.46 | 35.88 | Highly Overvalued | 294.00 | 25.98 | 209.00 |
| 4 | Aarti Pharmalabs Ltd | 7.46 | 35.90 | Neutral | 369.00 | 19.44 | 175.00 |
| 5 | Innova Captab Ltd | 7.36 | 38.55 | Overvalued | 243.00 | 14.63 | 141.00 |
| 6 | Akums Drugs & Pharmaceuticals Ltd | 7.28 | 37.30 | Overvalued | 522.00 | 7.09 | 256.00 |
| 7 | Marksans Pharma Ltd | 7.24 | 28.16 | Neutral | 601.00 | 6.64 | 420.00 |
| 8 | Hikal Ltd | 7.13 | -51.71 | Neutral | 220.00 | -3.95 | -49.00 |
| 9 | RPG Life Sciences Ltd | 7.12 | 32.70 | Neutral | 147.00 | 69.64 | 115.00 |
| 10 | Shilpa Medicare Ltd | 5.94 | 44.32 | Highly Overvalued | 435.00 | 6.80 | 243.00 |
| 11 | Strides Pharma Science Ltd | 5.55 | 18.41 | Undervalued | 925.00 | 19.92 | 575.00 |
| 12 | Jeena Sikho Lifecare Ltd | 5.52 | 31.22 | Neutral | 349.00 | 17.87 | 222.00 |
| 13 | Gufic BioSciences Ltd | 5.49 | 55.51 | Neutral | 151.00 | 6.30 | 64.00 |
| 14 | Dishman Carbogen Amcis Ltd | 5.38 | 27.45 | Neutral | 566.00 | -2.45 | 97.00 |
| 15 | Aarti Drugs Ltd | 5.07 | 17.34 | Undervalued | 309.00 | 18.54 | 195.00 |
| 16 | Orchid Pharma Ltd | 4.85 | 241.74 | Neutral | 41.00 | 8.91 | 21.00 |
| 17 | Sequent Scientific Ltd | 4.61 | 293.05 | Overvalued | 162.00 | 0.63 | 32.00 |
| 18 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.97 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 19 | Zota Health Care Ltd | 3.97 | -61.25 | Neutral | 19.00 | 8.06 | -74.00 |
| 20 | Procter & Gamble Health Ltd | 3.45 | 31.71 | Neutral | 457.00 | 196.94 | 327.00 |
| 21 | Sanofi India Ltd | 3.45 | 18.76 | Neutral | 491.00 | 134.52 | 413.00 |
The management of Jeena Sikho Lifecare Ltd is assessed as effective, demonstrating strengths in financial performance, capital efficiency, and financial prudence. While there are mixed signals in shareholding patterns, the overall trajectory suggests capable leadership focused on growth and financial stability. The company's strong profit growth and improved operational efficiency, combined with reduced borrowings, underscore effective management. However, trends in shareholding require monitoring.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (TTM) | 40% | Demonstrates robust revenue expansion |
| Profit Growth (TTM) | 212% | Reflects substantial profitability improvements | |
| ROCE | 59.08% | Indicates productive use of capital | |
| ROE | 43.52% | Signals good returns on shareholder funds | |
| Borrowings (Mar 2023) | ₹ 1 Cr | Indicates improved debt management | |
| CONS | Promoter holding change (Mar 2024 to Mar 2025) | 67.91% to 63.53% | Decreasing trend |
Financial Performance & Growth
Jeena Sikho Lifecare exhibits strong financial performance and growth. The Compounded Sales Growth (TTM) is 40%, indicating robust revenue expansion. The Compounded Profit Growth (TTM) is significantly high at 212%, reflecting substantial profitability improvements. The Operating Profit Margin (OPM) has improved from 12% in Mar 2022 to 22% in Mar 2023, showcasing enhanced operational efficiency. Sales Growth % increased from Mar 2022 to Mar 2023 which is 39.69%.
| Metric | Mar 2022 | Mar 2023 |
|---|---|---|
| Sales | 147 | 205 |
| Sales Growth % | - | 39.69% |
| Operating Profit | 18 | 46 |
| OPM % | 12% | 22% |
Capital Efficiency & Returns
The company demonstrates strong capital efficiency and returns. The Return on Capital Employed (ROCE) stands at 59.08%, indicating productive use of capital. The Return on Equity (ROE) is also high at 43.52%, signaling good returns on shareholder funds. The Cash Conversion Cycle has improved significantly from 62 days in Mar 2022 to -1 day in Mar 2023, demonstrating efficient working capital management.
| Metric | Mar 2022 | Mar 2023 |
|---|---|---|
| ROCE % | - | 52% |
| ROE % | - | 43.52% |
| Cash Conversion Cycle | 62 | -1 |
Financial Health & Prudence
Jeena Sikho Lifecare shows good financial health and prudence. Borrowings have decreased from ₹ 7 Cr in Mar 2022 to ₹ 1 Cr in Mar 2023, indicating improved debt management. Dividend Payout has increased from 0% in Mar 2022 to 8% in Mar 2023, reflecting a willingness to share profits with shareholders.
| Metric | Mar 2022 | Mar 2023 |
|---|---|---|
| Borrowings | 7 | 1 |
| Dividend Payout % | 0% | 8% |
Shareholding & Ownership Structure
The shareholding pattern of Jeena Sikho Lifecare indicates mixed signals. While Promoter holding has decreased from 67.91% in Mar 2024 to 63.53% in Mar 2025, FII holding has increased from 0.26% in Mar 2024 to 5.95% in Mar 2025.
| Shareholder Type | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Promoters | 66.20% | 67.91% | 63.53% |
| FIIs | 0.00% | 0.26% | 5.95% |
| DIIs | 0.00% | 0.00% | 0.17% |
| Public | 33.80% | 31.83% | 30.34% |
Jeena Sikho Lifecare Ltd presents a moderate risk profile due to fluctuations in shareholding patterns. The company's strong financial performance and reduced borrowings are positive indicators, mitigating some concerns. However, changes in promoter and FII holdings require close monitoring to ensure sustained stability and investor confidence.
Off-balance sheet exposure quantification
There is no specific data available on off-balance sheet exposure quantification.
Contingent liability evaluation
There is no specific data available on contingent liability evaluation.
Accounting quality red flags
There is no specific data available on accounting quality red flags.
Segment performance volatility
There is no specific data available on segment performance volatility.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10552.11Bullish
- SMA 20563.26Bearish
- SMA 50584.41Bearish
- EMA 10555.94Bullish
- EMA 20563.40Bearish
- EMA 50580.49Bearish
- DEMA 10550.90Bullish
- DEMA 20548.82Bullish
- DEMA 50559.78Bearish
- TEMA 10554.70Bullish
- TEMA 20546.61Bullish
- TEMA 50552.46Bullish
- MACD-10.54Bullish
- ADX18.89Weak Trend
- IndicatorValueSignal
- RSI36.13Neutral
- CCI-33.07Neutral
- ROC 91.37Bullish
- ROC 14-2.97Bearish
- ROC 25-6.68Bearish
- Stoch K27.07Neutral
- Stoch D20.86Neutral
- IndicatorValueSignal
- BB Upper592.72Neutral
- BB Middle563.26Neutral
- BB Lower533.80Neutral
- ATR7.60Low Volatility
- IndicatorValueSignal
- MFI41.81Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10558.06Bearish
- SMA 20579.52Bearish
- SMA 50603.99Bearish
- EMA 10561.29Bearish
- EMA 20572.71Bearish
- EMA 50593.30Bearish
- DEMA 10549.77Bullish
- DEMA 20554.41Bullish
- DEMA 50566.72Bearish
- TEMA 10550.10Bullish
- TEMA 20548.40Bullish
- TEMA 50560.09Bearish
- MACD-14.13Bearish
- ADX15.57Weak Trend
- IndicatorValueSignal
- RSI34.00Neutral
- CCI-72.47Neutral
- ROC 9-3.66Bearish
- ROC 14-6.34Bearish
- ROC 25-6.11Bearish
- Stoch K16.89Oversold
- Stoch D12.49Oversold
- IndicatorValueSignal
- BB Upper626.71Neutral
- BB Middle579.52Neutral
- BB Lower532.33Neutral
- ATR12.08Low Volatility
- IndicatorValueSignal
- MFI45.27Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10578.68Bearish
- SMA 20590.09Bearish
- SMA 50615.73Bearish
- EMA 10572.12Bearish
- EMA 20587.22Bearish
- EMA 50613.53Bearish
- DEMA 10554.51Bullish
- DEMA 20563.82Bearish
- DEMA 50585.82Bearish
- TEMA 10549.10Bullish
- TEMA 20557.85Bearish
- TEMA 50N/AN/A
- MACD-18.33Bearish
- ADX12.40Weak Trend
- IndicatorValueSignal
- RSI37.88Neutral
- CCI-131.23Oversold
- ROC 9-9.63Bearish
- ROC 14-4.27Bearish
- ROC 25-19.55Bearish
- Stoch K8.53Oversold
- Stoch D6.45Oversold
- IndicatorValueSignal
- BB Upper634.99Neutral
- BB Middle590.09Neutral
- BB Lower545.18Neutral
- ATR24.13Low Volatility
- IndicatorValueSignal
- MFI47.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10596.05Bearish
- SMA 20610.14Bearish
- SMA 50652.93Bearish
- SMA 100650.22Bearish
- SMA 200693.78Bearish
- EMA 10592.38Bearish
- EMA 20610.60Bearish
- EMA 50634.56Bearish
- EMA 100648.53Bearish
- EMA 200637.51Bearish
- DEMA 10572.44Bearish
- DEMA 20582.74Bearish
- DEMA 50612.60Bearish
- DEMA 100635.59Bearish
- DEMA 200694.48Bearish
- TEMA 10567.77Bearish
- TEMA 20570.20Bearish
- TEMA 50600.29Bearish
- TEMA 100606.74Bearish
- TEMA 200648.90Bearish
- MACD-21.60Bearish
- ADX11.26Weak Trend
- IndicatorValueSignal
- RSI39.14Neutral
- CCI-114.57Oversold
- ROC 14-10.65Bearish
- ROC 25-23.20Bearish
- Stoch K31.22Neutral
- Stoch D38.01Neutral
- IndicatorValueSignal
- BB Upper693.36Neutral
- BB Middle610.14Neutral
- BB Lower526.92Neutral
- ATR44.04Low Volatility
- IndicatorValueSignal
- MFI74.62Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 20644.41Bearish
- SMA 50673.16Bearish
- EMA 20648.87Bearish
- EMA 50624.25Bearish
- DEMA 20639.72Bearish
- DEMA 50706.76Bearish
- TEMA 20622.04Bearish
- TEMA 50670.81Bearish
- MACD-7.34Bearish
- ADX20.39Weak Trend
- IndicatorValueSignal
- RSI48.12Neutral
- CCI-70.12Neutral
- ROC 141.19Bullish
- ROC 25-16.20Bearish
- Stoch K40.15Neutral
- Stoch D40.27Neutral
- IndicatorValueSignal
- BB Upper737.93Neutral
- BB Middle644.41Neutral
- BB Lower550.89Neutral
- ATR86.69Low Volatility
- IndicatorValueSignal
- MFI10.39Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6630.53Bearish
- SMA 12643.25Bearish
- SMA 24495.23Bullish
- EMA 6628.70Bearish
- EMA 12601.57Bullish
- EMA 24503.80Bullish
- DEMA 6631.00Bearish
- DEMA 12680.57Bearish
- DEMA 24708.12Bearish
- TEMA 6609.03Bullish
- TEMA 12650.58Bearish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX67.60Strong Trend
- IndicatorValueSignal
- RSI64.74Neutral
- CCI119.30Overbought
- ROC 25201.74Bullish
- ROC 50N/AN/A
- Stoch K77.41Neutral
- Stoch D83.44Overbought
- IndicatorValueSignal
- BB Upper836.50Neutral
- BB Middle542.23Neutral
- BB Lower247.96Neutral
- ATR115.55High Volatility
- IndicatorValueSignal
- MFI48.96Neutral